Evidence map›Paper›PMID 27841741›Full record

ArticleHealth marketing quarterly

Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Kathryn J Aikin, Helen W Sullivan, Amie C O'Donoghue, Kevin R Betts

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health marketing quarterly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathryn J Aikina Office of Prescription Drug Promotion , U.S. Food and Drug Administration , Silver Spring , Maryland , USA.
Helen W Sullivana Office of Prescription Drug Promotion , U.S. Food and Drug Administration , Silver Spring , Maryland , USA.
Amie C O'Donoghuea Office of Prescription Drug Promotion , U.S. Food and Drug Administration , Silver Spring , Maryland , USA.
Kevin R Bettsa Office of Prescription Drug Promotion , U.S. Food and Drug Administration , Silver Spring , Maryland , USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Information on the effects of promotional offers in direct-to-consumer prescription drug ads is limited. In two studies, we examined the effect of promotional offers (e.g., money-back guarantee) and ad type (creating prescription and over-the-counter drug ads by varying the presence of benefit and risk information). We found little effect of promotional offers. Adding benefit (risk) information to the ad increased consumers' knowledge of the benefit (risk) information and their efficacy (risk) perceptions. In most cases, adding risk information to an ad with benefit information increased risk knowledge and perceptions without decreasing benefit knowledge or perceptions.

Indexed as

AdvertisingNonprescription DrugsPrescription DrugsDrug IndustryHumansPerceptionPublic OpinionRisk AssessmentNonprescription DrugsPrescription DrugsAdvertisementscouponsdrug safetyDTCOTCprescription drugspromotional offersrisk comprehensionrisk perception

Identifiers

PMID27841741
PMCPMC8218607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.